A new trend of cross-country collaborations on pricing and reimbursement in Europe seems to be taking off, but these potentially transformative initiatives will only work if they abide by certain principles, says the European Federation of Pharmaceutical Industries and Associations. Such collaborations must improve access to medicines, avoid duplication and delay, and be voluntary, EFPIA advises.
The federation points to initiatives that have joined or are seeking to join forces to improve access to medicines, such as BeNeLuxA-I (made up of Belgium, the Netherlands, Luxembourg, Austria...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?